entertainment -WSS

entertainment

author：leisure time 2025-09-07 14:11:50 - browse：68

Both Humana and CVS Health on Wednesday touted plans to aggressively scale their primary care clinics for seniors and funnel Medicare members into those clinics.

It’s a formula that’s been mastered by UnitedHealth Group, which is both the country’s largest Medicare Advantage insurer and one of the biggest physician employers. Even so, investors signaled they think Humana and CVS can catch up, sending both companies’ stock prices higher after their respective second quarter earnings calls Wednesday morning.

Both Humana and CVS, which owns the insurer Aetna, have made major leaps into primary care for older adults in recent years. Humana is partnering with a private equity firm to add more CenterWell Senior Primary Care sites, while CVS bought the Medicare provider Oak Street Health in May.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Congress might make insulin pumps more accessible to the blind

leisure time

WSS

Why more medical students aren't specializing in primary care

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Departing Stanford president retracts two papers

Bernie Sanders gets little from pharma CEOs on drug prices

Readout Newsletter: Amylyx, Aurinia, and IQVIA

AMAs digital advisors table RPM coding reform proposal, again

knowledge

entertainment

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

As pharma fights Medicare drug negotiation, hospitals, docs silent

Virginia high school admissions case could be legal follow

Doctors on social media are being harassed and cyberbullied

Activists slam private health insurers over coverage restrictions

Websites selling Wegovy, Zepbound ingredients targeted by FDA

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bernie Sanders gets little from pharma CEOs on drug prices

Bright Health sells Medicare Advantage business to Molina

Bernie Sanders gets little from pharma CEOs on drug prices

entertainment

How a symptom of dementia informs our understanding of creativity

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Bernie Sanders gets little from pharma CEOs on drug prices

Diversity in medical illustrations gets boost from Chidiebere Ibe

AstraZeneca bets AAV gene therapy will still deliver the goods

leisure time

leisure time

focus

hotspot